Document Detail

[Novel anticoagulants for stroke prevention in atrial fibrillation].
MedLine Citation:
PMID:  21064013     Owner:  NLM     Status:  MEDLINE    
The most frequent cardiac arrhythmia and main cause for cardio-embolic stroke is atrial fibrillation. Prophylaxis for thrombembolic events is performed regarding individual risk of patients with either ASS or vitamin-K-antagonists. Efficacy and safety of oral anticoagulation is limited by a narrow therapeutical range as well as by inter- and intraindividual variability of INR-values due to genetic disposition, differences in alimentation, dosage errors, rare control of INR-levels and drug-interactions. New oral anticoagulants with different mechanisms of action may be a promising therapeutic option in future. This review addresses the new anticoagulants Apixaban, Rivaroxban and Dabigatranetexilat with the design and as available the results of the corresponding phase-III-trials in atrial fibrillation (ARISTOTLE, ROCKET-AF, RE-LY).
M Baumhäkel; S H Schirmer; M Böhm
Related Documents :
10357153 - Use of argatroban during percutaneous coronary interventions in patients with heparin-i...
8414023 - Thalamic infarctions: differential effects on vestibular function in the roll plane (35...
8444003 - Spontaneous secure reimplantation of a dislodged pacemaker electrode onto the right ven...
Publication Detail:
Type:  English Abstract; Journal Article; Review     Date:  2010-11-09
Journal Detail:
Title:  Deutsche medizinische Wochenschrift (1946)     Volume:  135     ISSN:  1439-4413     ISO Abbreviation:  Dtsch. Med. Wochenschr.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-10     Completed Date:  2010-12-02     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  0006723     Medline TA:  Dtsch Med Wochenschr     Country:  Germany    
Other Details:
Languages:  ger     Pagination:  2304-8     Citation Subset:  IM    
Copyright Information:
© Georg Thieme Verlag KG Stuttgart · New York.
Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes.
Vernacular Title:
Neue Antikoagulanzien für die Thromboembolieprophylaxe bei Vorhofflimmern.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / classification,  therapeutic use*
Antithrombins / therapeutic use
Atrial Fibrillation / complications*,  drug therapy
Azetidines / therapeutic use
Benzimidazoles / therapeutic use
Benzylamines / therapeutic use
Clinical Trials, Phase III as Topic
Factor Xa / antagonists & inhibitors
Fibrinolytic Agents / classification,  therapeutic use*
Morpholines / therapeutic use
Pyrazoles / therapeutic use
Pyridines / therapeutic use
Pyridones / therapeutic use
Stroke / prevention & control*
Thiophenes / therapeutic use
Thromboembolism / prevention & control*
Reg. No./Substance:
0/Anticoagulants; 0/Antithrombins; 0/Azetidines; 0/Benzimidazoles; 0/Benzylamines; 0/Fibrinolytic Agents; 0/Morpholines; 0/Pyrazoles; 0/Pyridines; 0/Pyridones; 0/Thiophenes; 0/rivaroxaban; 2E18WX195X/dabigatran etexilate; 3Z9Y7UWC1J/apixaban; 49HFB70472/ximelagatran; EC Xa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [Polycythemia].
Next Document:  [52-year-old patient with transient exanthema, fever, and arthralgias. Adult-onset Still's disease].